Insufficienza Renale Cronica e Danno Carotideo

Gurland H.J. , Brunner F.P. , Dehn H.V. , Harlen H. , Parsons F.M. , Scharer K. Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 1973; 10: XVII–LVII.

Burton B.T. , Krueger K.K. , Bryan F.A. Jr. : National Registry of long-term dialysis patients. JAMA 218: 718–722; 1971.

Degoulet P. , Legrain M. , Reach I. Mortality risk factors in patients treated by chronic hemodyalisis. Nephron 31: 103–110; 1982.

Lindner A. , Charra B. , Sherrard D. , Scribner B.H. : Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697–701; 1974.

Broyer M. , Brunner F.P. , Brynger H. Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 19: 2–60; 1982.

Ibels L.S. , Stewart J.H. , Mahony J.F. , Neale F.C. , Sheil G.R. Occlusive arterial disease in uraemic and hemodialysis patients and renal transplant recipients. Q J Med 44: 197–214; 1977.

King W.M. , Greene E.L. , Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis population. Am J Kidney Dis 19: 505–13, 1992.

Zucchelli P. , Santoro A. , Zuccala A. Genesis and control of hypertension in hemodialysis patients. Semin Nephrol 8: 163–8; 1988.

Appel G. Lipid abnormalities in renal disease. Kidney Int 39: 169–83; 1991.

Cramp D.G. Plasma lipid alterations in patients with chronic renal disease. CRC Crit Rev Clin Lab Sci 17: 77–101; 1982.

Parra H.J. , Mezdour H. , Cachera C. , Dracon M. , Tacquet A. , Fruchart J.C. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 1987; 33: 721–1.

Attman P. , Alaupovic P. , Gustavson A. Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 1987; 32: 368–75.

Grutzmacher P. , Marz W. , Peschke B. , Gross W. , Schoeppe W. Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron 1988; 50: 103–11.

Attman P. , Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia-Relation to renal function and dialysis. Nephron 1991; 57: 401–10.

Jubiliber S.J. Hemostatic abnormalities in renal disease. Am J Kidney Dis 1985; 5: 219–25.

Warwick G.L. , Packard C.J. Lipoprotein metabolism in the nephrotic syndrome. Nephrol Dial Transplant 1993; 8: 385–96.

Radhakrishnan J. , Appel A.S. , Valeri A. , Appel G.B. The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis 1993; 22: 135–42.

Tell G.S. , Howard G. , Mc Kinney W.M. , Toole J.F. Cigarette smoking cessation and extracranial carotid atherosclerosis. JAMA 1989; 261: 1178–80.

Burstein M. , Scholnick H.R. , Morgin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583–95.

Friedwald W.T. , Levy R.I. , Fredrickson D.S. Estimation of plasma low density lipoproteins cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–509.

Fless G.M. , Snyder M.L. , Scanu A.M. Enzyme-linked immunoassay for Lp(a). J Lipid Res 1989; 30: 651–61.

Felix WR Jr. . Duplex ultrasound scanning for carotid artery disease. In: noninvasive diagnosis of peripheral vascular disease. New York, NY: Raven Press, 1988; 107.

Pignoli P. , Tremoli E. , Poli A. , Oreste P.L. , Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399–406.

Rossi G.P. , Rossi A. , Zanin L. Excess prevalence of extracranial carotid artery lesions in renovascular hypertension. Am J Hypertension 1992; 5: 8–15.

Rossi G.P. , Rossi A. , Zanin L. , Calabrò A. , Crepaldi G. , Pessina A.C. Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism. Am J Hypertension 1993; 6: 8–14.

Salonen R. , Seppanen K. , Raurama R. , Salonen J.K. Prevalence of carotid atherosclerosis and serum cholesterol levels in Eastern Finland. Arteriosclerosis 1988; 8: 788–92.

Tell G.S. , Howard G. , McKinley W.M. Risk factors for site specific extracranial carotid artery plaque distribution as measured by B-mode ultrasound. J Clin Epidemiol 1989; 42: 551–59.

Hennerici M. , Reifschneider G. , Trockel U. , Aulich A. Detection of early atherosclerotic lesions by duplex scanning of the carotid artery. J Clin Ultrasound 1984; 12: 455–64.

Poli A. , Tremoli E. , Colombo A. , Sirtori M. , Pignoli P. , Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988; 70: 253–61.

Roussel L. , Steyaert L. , Meeus L. , Vandevoorde P. , Devos V. , Patyn G. Duplex sonography of the cervical carotid artery. Part II: Confrontation with angiography. Criteria for flow restrictive stenoses. JBR-BTR 1988; 71: 589–600.

Cranley J.J. Jr. , Carcow W.S. , Baldridge E.D. Atlante di Duplex scanner. Torino, Italy: Centro Scientifico Editore, 1990; 41–83.

Rosner B. Fundamentals of Biostatistics. Boston, Massachusetts: Duxbury Press, 1986; 333–68.

Godfrey K. Comparing the means of several groups. In: Bailar J.C. III , Mosteller F. eds. Medical Uses of Statistics. Boston, Massachusetts: NEJM Books, 1992; 233–57.

Kleinbaum D.G. , Kupper L.L. , Muller K.E. Applied regression analysis and other multivariable methods. Boston, Massachusetts: PWS Kent Publ. Co, 1988; 102–114.

Neveling M. , Hoier C. , Bewermeyer H. , Mertens M. B scan ultrasound findings in the carotid bifurcation area of hemodialysis patients. Ultraschall Med 1992; 13: 127–31.

Bernardi D. , Ferreri A. , Moretti P. , Nesti E. , Urti D.A. , Bonechi I. Carotid artery atherosclerotic disease assessed by flow velocity wave form analysis in hemodialyzed normotensive and hypertensive patients. Nephron 1986; 44: 180–5.

Baumgart P. , Walger P. , Gerke M. , Dorst K.G. , Vetter H. , Rahn K.H. : Nocturnal hypertension in renal failure, haemodialysis and after renal transplantation. J Hypertens 1989; 7(Suppl): S70–1.

Vincenti F. , Amend W. , Abele J. , Feduska N.J. , Salvatierra O. The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 1980; 68: 363–9.

Wilhelmsen L. , Svardsudd K. , Korsan-Bengtsen K. , Larsson B. , Welin L. , Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–5.

Meade T.W. , Brozovic M. , Chakrabarti R.R. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533–7.

Cook N.S. , Ubben D. Fibrinogen as a major risk factor in cardiovascular disease. Trends Pharmacol Sci 1990; 11: 444–51.

Moller L. , Kristensen T.G. Plasma fibrinogen and ischemic heart disease risk factor. Arterioscl Thromb 1991; 11: 344–50.

Qizilbash N. , Jones L. , Warlow C. , Mann J. Fibrinogen and lipid concentration as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br Med J 1991; 303: 605–9.

Clark W.M. , Coull B.M. , Beamer N.B. Need for treatment of elevated plasma fibrinogen levels in cerebrovascular disease. Heart Disease and Stroke 1993; 2: 503–6.

Yarnell J.W.G. , Baker I.A. , Sweetnam P.M. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Spedwell collaborative heart studies. Circulation 1991; 83: 836–44.

Ensrud K. , Grimm R.H. Jr. The white blood cell count and risk for coronary heart disease. Am Heart J 1992; 124: 207–13.

Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–9.

Jackson M.H. , Collier A. , Nicoli J.J. Neutrophil count and activation in vascular disease. Scott Med J 1992; 37: 41–3.

Tornvall P. , Bavenholm P. , Landou C. , De Faire U. , Hamsten A. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88: 2180–9.

Castelli W.P. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992; 70: 3H–9H.

Gotto A.M. Hypertrygliceridemia: risks and perspectives. Am J Cardiol 1992; 70: 19H–25H.

Cheung A.K. , Wu L.L. , Kablitz C. Leypoldt JK. Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 1993; 22: 271–6.

Steinber D. , Parthasarathy S. , Care T.E. , Khoo J.C. , Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–24.